6Parkin DM,Bray F,Feday J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74-108. 被引量：1
7Sakata Y,Ohtsu A,Horikoshi N,et al.Late phase Ⅱ study of novel oral fluoropyrimidine antieaneer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otsstat potassium) in advanced gastric cancer patients[J].Eur J Cancer,1998,34(11):1715-1720. 被引量：1
8Koizumi W,Kurihara M0 Nakano S,et al.Phase Ⅱ study of S-1,a novel oral derivative of 5-fluorouracil,in advanced gastric cancer.For the S-1 Cooperative Gastric Cancer Study Group[J].Oncology,2000,58(3):191-197. 被引量：1
9Chollet P,Schoffski P,Weigang-Kohler K,et al.Phase Ⅱ trial with S-1 in ehemotherapy-naive patients with gastric cancer.A trial performed by the EORTC Early Clinical Studies Group (ECSG)[J].Eur J Cancer,2003,39(9):1264-1270. 被引量：1
10Koizumi W,Tanabe S,Saigenji K,etal.Phase Ⅰ / Ⅱ study of S-1 combined with eisplatin in patients with advanced gastric cancer[J].Br J Cancer,2003,89(12):2207 -2212. 被引量：1
